Top 50 Biotechnology VC (Venture Capital) Funds in Japan in September 2025
A list of 50 VC (Venture Capital) funds that invest in Biotechnology startups based in Japan. We rank investors based on the number of investments they made in Biotechnology companies from Japan. We update this investor list every month.Top 50 Biotechnology VC (Venture Capital) Funds in Japan in September 2025
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more
Investment focus
- Information Technology, Software, Health Care
- Funding Round, Series A, Series B
- Japan, United States, Singapore
Portfolio highlights
- LiLz — LiLz is an IT technology network for businesses looking to use AI and IoT to offer new services and value.
- Trustart — Trustart engages in real estate research business and real estate big data provision. The company offers real estate big data and big data subscriptions.
- FUNDiT — FUNDiT is an IT-focused M&A and business consolidation company that specializes in acquiring, managing, and scaling IT companies.
UntroD Capital is an R&D-based innovative technology that specializes in social implementation.
Show more
Investment focus
- Manufacturing, Biotechnology, Health Care
- Funding Round, Seed, Series A
- Japan, Singapore, Austria
Portfolio highlights
- CyCraft — CyCraft secures national governments, Fortune 500 firms, and SMEs with our Japan Interop 2020 Best of Show and MITRE ATT&CK®-evaluated AI platform, CyCraft AIR, that delivers 1) endpoint detection & response, 2) network detection & response, 3) operational global threat intelligence and 4) enterprise cyber-health checks.
- Innovacell — Innovacell is a biotechnology firm entirely focused on the area of tissue engineering and it operates one of Europe's largest and most modern production facilities for the proliferation of the body's own tissue cells. Its supervisory board is chaired by the experienced financial expert, Dr. Harald Pöttinger, a director of Alpine EquityManagement AG, based in Bregenz, Austria. Innovacell currently employs 20 staff as well as numerous outside experts.
- Reborna Biosciences — Reborna Biosciences provides research and development in the field of genetic diseases. The company develops therapeutic options for area of unmet medical needs in genetic rare disease. The company's technology enables low-molecular compounds to target ribonucleic acid. The company provides new disease-modifying drugs for patients sufferingfrom rare genetic diseases including spinal muscular atrophy.
Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology.
The firm was founded in 2014 and based in Osaka, Japan.
Show more
Investment focus
- Biotechnology, Manufacturing, Health Care
- Funding Round, Seed, Series A
- Japan
Portfolio highlights
- Ayumo — Ayumo is a research and development company that provides deep learning services with medical insights and AI technology.
- RegCell — RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
- EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Seed, Funding Round
- Japan, United States, United Kingdom
Portfolio highlights
- Ichirou — Ichirou provides digital senior care support services to connect elderly people with caretakers. It offers caretaker services for different types of support, including housework, hospital care, nursing, hospital and doctor visits, and shopping assistance.
- RegCell — RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.
Show more
Investment focus
- Information Technology, Software, Health Care
- Funding Round, Series A, Series B
- Japan, United States, Singapore
Portfolio highlights
- Trustart — Trustart engages in real estate research business and real estate big data provision. The company offers real estate big data and big data subscriptions.
- Visual Bank — Visual Bank operates a stock photo business and provides an AI data platform. It aims to create a society in which the value of Japanese creations is maximized and optimized.
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Funding Round
- Japan, United States, India
Portfolio highlights
- Chorakuchoju — Chorakuchoju is a healthcare organization that tries to avoid isolation by implementing AI technologies and medical services.
- Linea Innovations — Linea Innovations is an energy production company that develops commercial fusion reactors with advanced fuel technology.
- Strand Therapeutics — Strand Therapeutics is developing the first platform for creating programmable mRNA drugs to deliver precise, multi-functional, potentially curative treatments.
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Funding Round, Seed
- Japan, United Kingdom
Portfolio highlights
- Waku — Waku is a manufacturing company that specializes in the research and development of organic fertilizers for the agriculture industry.
- Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Funding Round
- Japan, United States, Singapore
Portfolio highlights
- Alumnote — The alumni association management software developed by Alumnote allows schools to manage their alumni associations online. The focus of the company is to undertake loyalty building and marketing for potential donors such as graduates and provides digital tools, and supports the execution of donation acquisition.
- Peach Cars — Buy or sell your car in Nairobi-Kenya with ease. Browse a wide range of vehicles, connect with trusted sellers, and find the perfect car today. Simple, fast, and secure transactions.
- Pahr Therapeutics — PAhR Therapeutics is a clinical-stage biotech company advancing innovative therapies to treat pulmonary arterial hypertension (PAH) through novel biological mechanisms.
Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.
Show more
Investment focus
- Information Technology, Software, Artificial Intelligence
- Series A, Funding Round, Series B
- Japan, United States, Israel
Portfolio highlights
- LayerX — LayerX which promotes the digitization of business processes utilizing technologies such as blockchain technology.
- Commune — Commune is a developer of a platform that supports connections, community building, and customers between organizations and people.
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization).
The firm was founded in 2014 and based in Tokyo, Japan.
Show more
Investment focus
- Manufacturing, Biotechnology, Medical
- Funding Round, Series A, Seed
- Japan, Singapore, Austria
Portfolio highlights
- Ashirase — Ashirase is a developer of a walking navigation system for the visually challenged. The company assists visually impaired people in walking independently. This also allows the user to have more attention to spare for audible warnings in their environment. It includes voice input and guidance via a smartphone app. A vibration interface is attachedto their shoes.
- Ken Robotec — Ken Robotec is a construction company that provides labor-saving solutions.
- MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.
SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.
Show more
Investment focus
- Information Technology, Software, Financial Services
- Series B, Series A, Funding Round
- Japan, South Korea, United States
Portfolio highlights
- Prorata.AI — ProrataAI builds technology that enables generative AIs to properly attribute contributing content and share revenues on a per-use basis.
- Innovacell — Innovacell is a biotechnology firm entirely focused on the area of tissue engineering and it operates one of Europe's largest and most modern production facilities for the proliferation of the body's own tissue cells. Its supervisory board is chaired by the experienced financial expert, Dr. Harald Pöttinger, a director of Alpine EquityManagement AG, based in Bregenz, Austria. Innovacell currently employs 20 staff as well as numerous outside experts.
- ASTRO — Situs Belanja Kebutuhan Harian Online dengan Harga Terjangkau dan Kualitas Terbaik. Pesan Kebutuhan Harian di ASTRO Pasti Sampai dalam Hitungan Menit
Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.
Show more
Investment focus
- Information Technology, Software, Internet
- Funding Round, Series A, Series B
- Japan, United States, China
Portfolio highlights
- Terass — TERASS is a High-end real estate information site.
- Helical Fusion — Helical Fusion is a startup company that aims to commercialize fusion energy using magnetic confinement of high-temperature plasmas.
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more
Investment focus
- Health Care, Internet, Information Technology
- Funding Round, Seed, Series A
- Japan, United States, Ethiopia
Portfolio highlights
- Japan AI — Japan AI specializes in R&D of artificial intelligence and consulting services.
- Blackbox — Blackbox is an entertainment firm that is involved in businesses, including VTuber production, media mix, and live music events.
- Linea Innovations — Linea Innovations is an energy production company that develops commercial fusion reactors with advanced fuel technology.
DBJ Capital Co., Ltd. was founded in June 2010 through the integration of two venture capital firms of the DBJ Group, New Business Investment Co., Ltd. and Intellectual Properties Development & Investment, Inc. We are a wholly-owned subsidiary of Development Bank of Japan Inc.At DBJ Capital, we focus on venture firms which use newtechnologies and business models to grow and compete on the global market, regardless of their industry or scale. To meet the particular needs of each client, we mobilize the entire DBJ Group to arrange the best investment solutions, ranging from growth-spurring equity investment to financing schemes drawing on DBJ's vast networks.We also assist in venture start-ups. Our value enhancement team provides the kind of comprehensive, hands-on support needed to commercialize outstanding intellectual property and technologies developed by firms, research labs, and universities, and to carve out a place for them in the market.DBJ Capital will continue to play in a part in Japan's economic revival - by helping the firms we invest in to grow, and by encouraging the creation of new industries in Japan.
Show more
Investment focus
- Software, Health Care, Medical
- Funding Round, Series A, Series B
- Japan, United States, Australia
Portfolio highlights
- Anaguma — Anaguma handles business development based on the philosophy of helping people with a sustainable structure. The company's business objective is to eliminate concerns about purchases and reservations, and it delivers before-sales social networks. It also provides matching services exclusively for housekeepers' personal contracts. Thecompany also offers influencer marketing services with a focus on removing waste completely from advertising and realizing a world in which good products can be sold regardless of advertising costs.Anaguma was founded in January 2016 and is headquartered in Tokyo, Japan.
- Ageless — Ageless is a staffing agency that provides human resources-related services primarily to middle-aged and senior citizens.
- Forest — Forest Co., Ltd. operates as an e-commerce aggregator, seeks to identify sustainable, high-quality products and brands that embrace the spirit of Japan and help them grow and enter the global market by using the power of technology.
Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services.2) Agri-Food: Industrialization,agricultural and fishery products growth-promoting technology, specified health food, health food.3) Environment, Energy: Alternative energy, and related technologies.4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot.5) New services utilizing state-of-art technology.Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.
Show more
Investment focus
- Medical, Biotechnology, Information Technology
- Series A, Seed, Series B
- Japan, United States, United Kingdom
Portfolio highlights
- Mui Lab — Mui is an aesthetically-pleasing wooden IoT device connected to a cloud service. By accessing information through natural wood, we can rethink a new type of lifestyle.
- Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
- Oishii — Oishii Farm provides indoor vertical farming technology. Oishii sells via supermarkets, offering a container of between eight and 11 strawberries for $50 per package. Hiroki Koga and Brendan Somerville started the company in 2017.
Future Venture Capital Co., Ltd. is a venture capital firm specializing in early stage investment. The firm invests in diversified investment in a broad range of industrial sectors. It seeks to invest in Japan. The firm prefers to be the lead investor in its portfolio companies. Future Venture Capital Co., Ltd. was founded in 1998 and is based inKyoto, Japan with offices in Tokyo, Aomori, Iwate, Yamagata, Kanazawa, Mie, Sakai, Kobe, and Ehime.
Show more
Investment focus
- Health Care, Information Technology, Manufacturing
- Funding Round, Seed, Series A
- Japan, United States, Myanmar
Portfolio highlights
- Newmo — newmo delivers sustainable local public transportation create a user experience (UX) that people may utilize with peace of mind and comfort.
- Ashirase — Ashirase is a developer of a walking navigation system for the visually challenged. The company assists visually impaired people in walking independently. This also allows the user to have more attention to spare for audible warnings in their environment. It includes voice input and guidance via a smartphone app. A vibration interface is attachedto their shoes.
- ORENDA WORLD — ORENDA focuses on developing high-definition 3D simulation systems that apply gamification and real-time rendering technology.
Japan Science and Technology Agency is an integrated organization of science and technology that implements science and technology policy in Japan. It handles many projects, including the government’s Science and Technology Basic Plan and knowledge creation. The European Sustainability School ESSSR is the owner of Japan Science and TechnologyAgency.Japan Science and Technology Agency undertakes its task in a comprehensive manner. It also works to provide a sound infrastructure of science and technology information and raise awareness and understanding of science and technology-related issues in Japan.Japan Science and Technology Agency is headquartered in Tokyo, Japan.
Show more
Investment focus
- Medical, Biotechnology, Health Care
- Funding Round, Series A, Series B
- Japan
Portfolio highlights
- OptQC — OptQC commercializes cutting-edge optical quantum computing technologies developed by the Furusawa-Endo Laboratory. Because optical quantum computers are more scalable than superconducting and other quantum computing implementations, OptQC's optical quantum computers should reach this scale. They also have benefits like faster processing andreduced power consumption, which makes optical quantum computers a possible long-term pinnacle of quantum technology.
- Triorb — Triorb is a technology company that specializes in robot mobility development with the help of software and hardware solutions.
- RadioNano Therapeutics — RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a type of radiation therapy that utilizes the nuclear reaction between thermal neutrons and boron-10 (¹⁰B) to destroy cancer cells by releasing alpha particles and lithium nuclei.
FFG Venture Business Partners is a large-scale enterprise that offers in traditional regional bank venture capital.
Show more
Investment focus
- Software, Health Care, Artificial Intelligence
- Funding Round, Series A, Seed
- Japan, United States
Portfolio highlights
- FELIQS — FELIQS is a preclinical-stage start-up company established based on the robust science from molecular pathobiology, department of pharmaceutical science, Kyushu university.
- ATOMica — ATOMica is a co-working space and business management company for conference rooms, event venues, circles, and schools. The company uses coworking spaces as HUBs to provide services that maximize individuals' power. It can be used for a variety of purposes, including coworking space, shared office space, meetings, events, and web seminars. Itis also possible to use it only once. They plan and run local communities that bring together a diverse range of people, including students, workers, businesses, universities, and governments.
- OPTEMO — OPTEMO develops and supplies sales technology that allows businesses and customers to connect through a website.
Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.
Show more
Investment focus
- Software, Health Care, Information Technology
- Funding Round, Series A, Seed
- Japan, United States
Portfolio highlights
- Trustart — Trustart engages in real estate research business and real estate big data provision. The company offers real estate big data and big data subscriptions.
- Upward — UPWARD is highly by linking CRM · schedule map / location information, is a cloud service for the visiting business of field sales easier. Field salespersons who have many customers and who are out of the office feel that it is difficult to grasp all customers to Kampek and measure the timing of visits no matter how memorable they are.
- Tech Doctor — Tech Doctor is a health monitoring service which provides analysis and insights for self care reducing the need for health care workers.
Remiges Ventures is a venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Series A, Series B, Seed
- United States, Japan, Canada
Portfolio highlights
- Immunis — Currently seeking participants for age-related muscle atrophy (sarcopenia) clinical trails
- Cyrano Therapeutics — Cyrano Therapeutics is the leader in Smell Loss therapy and smell loss research. Recover your sense of smell today!
- KisoJi Biotechnology — KisoJi is a leading next-generation antibody company developing multi-specific antibodies to address difficult targets in oncology and other diseases
Incubate Fund is an independent early-stage venture capital that specializes in providing capital to technology startups at the seed stage. The firm built a portfolio of over 300 companies in Asia, taking 12 companies to public and 20 companies to M&A exit since 2010.
Show more
Investment focus
- Software, Information Technology, E-Commerce
- Seed, Funding Round, Series A
- Japan, United States, India
Portfolio highlights
- Visual Bank — Visual Bank operates a stock photo business and provides an AI data platform. It aims to create a society in which the value of Japanese creations is maximized and optimized.
- Nominal — Nominal empowers the next-generation economy.Nominal modernizes and automates accounting and financial management, providing robust reporting, multi-entity consolidation, workflow automation (including accruals and revenue), lease compliance (ASC 842/IFRS 16), period-end close collaboration, and much more.Nominal's generativesubledgers transform business logic into actions and insights using Generative AI - without the need for costly engineering or lengthy IT projects. Our shadow-ledger is implemented in days, not months, and seamlessly integrates with existing general ledgers and ERPs.
- Rocket Link Technology — Rocket Link Technology is a product development company that specializes in designing LTP rockets for space travel.
Fujifilm develops and sells consumer products and business products related to photography. Fujifilm Holdings Corporation is a Japanese multinational photography and imaging company. The company serves various industries, including medical, graphic arts, optics, enterprise storage, motion picture, and photography.The company’s consumer productsare categorized as digital cameras and accessories, film photography, Instax photography, and binoculars. Its business products are categorized as medical systems, Fujinon endoscopy, microfilm, data storage, graphic arts and printing, professional video, optical devices, specialty chemicals, printing imaging colorants, and more. Color films, digital cameras, photofinishing equipment, color papers, photofinishing chemicals, medical imaging equipment, graphic arts equipment and materials, flat panel displays, and photocopiers and printers are some products developed by Fujifilm USA.Fujifilm USA is based in Minato-ku, Tokyo, Japan.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Series B
- Japan, United States, China
Portfolio highlights
- Ripcord — Ripcord is a robotics company that combines hardware and software robotics via an integrated SaaS offering. Its focus is on smart robotics digitization, smart content management with AI, and helping enable RPA and business processes.Ripcord is based in Hayward, California, and is backed by leading investors Kleiner Perkins Caufield & Byers,Google Ventures, Lux Ventures, Legend Star, and Apple Co-Founder Steve Wozniak.
- 24M Technologies — 24M Technologies develops energy storage systems for grid and transportation applications. 24M Technologies, Inc. builds energy storage systems for grid and transportation applications. The company was founded in 2010 and is based in Cambridge, Massachusetts.
- Tome Biosciences — Tome Biosciences is a biotechnology company that develops programmable gene insertion technology. Using CRISPR, its technologies allow them to insert any genetic sequence of any size at any location into any genome.
DISCOVERY, DEVELOPMENT, DEPLOYMENT FOR GLOBAL HEALTH, WITH SCIENCE & BUSINESS ACUMEN
Show more
Investment focus
- Electronics, Medical Device, Artificial Intelligence
- Seed
Portfolio highlights
- RevolKa — RevolKa manufactures bio-products pharmaceuticals intended to serve the healthcare sector.
- Alpha Fusion — Alpha Fusion Inc. is a clinical-stage startup committed to transforming cancer treatment through the design and development of powerful and precise radiopharmaceuticals.
- Neros Technologies — Neros is vertically integrating production of unmanned defense systems in the United States, securing the autonomous supply chain. Are you with us?
F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- United States, United Kingdom, China
Portfolio highlights
- Apreo Health — Apreo Health is developer of medical apparatus designed for diagnosing or treating respiratory, pulmonary, and lung conditions.
- Dataplor — Leveraging machine learning, AI, and human capital, dataplor delivers verified international places data to the world's leading companies.
- Canary Technologies — Use Canary to securely conduct contactless check-in and process credit card authorizations, contracts, and amenities online. Canary is the only PCI Level-1 Compliant solution for hotel authorizations. Schedule a demo today, and see how we can help your properties reduce chargebacks, save time, and improve the guest experience.
Senshu Ikeda Capital offers financial consultancy services.
Show more
Investment focus
- Software, Internet, Information Technology
- Funding Round, Seed, Series A
- Japan
Portfolio highlights
- HOLO BIO — HOLO BIO is a research and technology firm that employs biological breeding techniques to address the food challenges faced by humanity.
- EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
- Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
DG Daiwa Ventures invests in start-up companies with next-generation technology and provides business development support. It is focused on blockchain, xR, AI, security, and BioHealth, as they are likely to be at the foundations of future businesses. In addition to the five core technologies, the fund will also focus on IoT technologies, whichoften overlap or serve as an application layer.
Show more
Investment focus
- FinTech, Software, Internet
- Seed, Funding Round, Series A
- Japan, United States, India
Portfolio highlights
- Lens — Lens ocuses on supporting corporate activities related to governance, risk management, compliance (GRC), and security.
- Zolve — Best neo bank in India offering international banking & financial services online. Apply for a US bank account, credit card & student education loan with Zolve!
- Acompany — Acompany provides products and consulting development related to secret computing.
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Funding Round
- United States, United Kingdom, Israel
Portfolio highlights
- Be Biopharma — Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.
- Degron Therapeutics — Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment.
- EvolveImmune Therapeutics — EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generatefirst-in-class treatments for unmet needs in oncology and autoimmune diseases.
KSP, Inc. is the core business entity responsible for operating the Kanagawa Science Park (KSP) and has accepted the challenge of creating new industries through the support, development, and incubation of venture businesses. We provide a variety of business support services that best meet the needs of venture businesses in each stage of theirbusiness growth, ranging from the processes of startup and growth to public offerings. Several hundreds of new startup companies have been created and nurtured since its foundation. An incubation manager (IM) acts as a coordinator and provides a variety of support services to a venture company to help them successfully launch and develop their new business, such as offering individual consultations and a variety of information or advice. KSP, Inc. is well poised to cope with the varying needs of new ventures for highly sophisticated, specialized tasks by offering a business school, business support center, business matching services, and investment funds.The public sector, such as the Kanagawa prefectural government, Kawasaki city government, and the Development Bank of Japan, Inc., has an equity participation in KSP, thus playing a vital role in the deployment of local industrial development policy.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Funding Round, Series A, Series B
- Japan
Portfolio highlights
- 3DC — 3DC develops and manufactures a new carbon material, graphene meso sponge (GMS), for electrodes in next-generation batteries, capacitors, fuel cells and other energy storage and generation devices.
- THE PHAGE — The phage is a medical device company that focuses on developing AI technology to predict postprandial blood glucose levels.
- Mira Robotics — Mira Robotics is a software based company provide services that can robots in various fields.
Tsukuba Institute of Research (筑波総研) is an R&D center owned by housing and wood products group Sumitomo Forestry. The facility develops technologies to make more effective use of wood in a wide range of fields.
Show more
Investment focus
- Medical, Biotechnology, Manufacturing
- Series A, Funding Round, Seed
- Japan
Portfolio highlights
- LIGHTz — LIGHTz delivers a technology transfer and information exchange platform leveraging AI.
- Celaid Therapeutics — Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
- Veneno Technologies — Veneno Technologies engages in the research and development of therapeutic disulfide-rich peptides and contribute to advanced medicine.
Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.
Show more
Investment focus
- Software, Health Care, Information Technology
- Series B, Series A, Series C
- United States, China, India
Portfolio highlights
- Swan — Use Swan's APIs to embed white-labeled banking features like accounts, cards, and IBANs into your workflows and UX.
- Safe Security — Incubated from IIT Bombay in 2012 and headquartered in Palo Alto, Lucideus has over 200 customers worldwide with an average NPS of 73.Backed by John Chambers and senior executives from SoftBank, Sequoia, PayPal, Adobe and McKinsey & Co., it was also one of the Top 5 Contributors to the NVD of the U.S. Government in 2019.Its platform, SAFE,allows an organization to get an Enterprise-Wide, Objective, Consistent & Real-Time Visibility of it’s overall Cyber Risk Posture. Built on supervised machine learning engine, SAFE gives an output both in the form of a breach likelihood score (between 0-5) and the $ value Risk the organization is sitting on, along with providing prioritized actionable insights based on technical cybersecurity signals, external threat intelligence, and business context of what and where are the "weakest links" across people, process and technology.The company, since 2018, has also been working with MIT for a joint research and development on the SAFE Scoring Algorithm and has received several awards including the Morgan Stanley CTO Innovation Award 2019.
- BlissClub — BlissClub is the community's first women's activewear brand.
Chushin Venture Capital is a venture capital fund established by Kyoto Chuo Shinkin Bank.
Show more
Investment focus
- Retail, Travel, Home Decor
- Series A, Series B
- Japan
Portfolio highlights
- Cizucu — Cizucu is a stock photo community that helps creators and brands to create photos.
- HOLO BIO — HOLO BIO is a research and technology firm that employs biological breeding techniques to address the food challenges faced by humanity.
- RadioNano Therapeutics — RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a type of radiation therapy that utilizes the nuclear reaction between thermal neutrons and boron-10 (¹⁰B) to destroy cancer cells by releasing alpha particles and lithium nuclei.
Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Grant, Funding Round, Corporate Round
- United States, Japan, China
Portfolio highlights
- Ascentage Pharma — As one of the leading clinical stage biopharmaceutical companies, we develop innovative therapies for global medical needs. Our biotech company is engaged in developing novel approaches for treating cancer.
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
- Atlanta Community Food Bank — We're on a mission to end hunger in our community. Learn more about how the Atlanta Community Food Bank provides hunger relief to families in need.
JIC-VGI helps promote innovation and improve its international competitiveness through growth-investments in startup companies. The firm accelerating innovation and helping to solve industrial and social issues by supporting and seeking innovative technologies and new businesses.JIC Venture Growth Investments was established in July 2020 and isbased in Tokyo, Japan.
Show more
Investment focus
- Information Technology, Software, Financial Services
- Series B, Series C, Funding Round
- Japan, Singapore, Thailand
Portfolio highlights
- Hacobu — Hacobu offers an integrated solution "MOVO (MOVO)" centering on the operation management system utilizing in-vehicle terminals. Connect with carriers and shipping companies sending luggage using an easy-to-use online mechanism. To provide tools to support the management of the shipping company. Through these, it becomes a platform toaccumulate distribution data of various companies, aiming at overall optimization of physical distribution system. That is, "to optimize carrying". That is Hacobu 's mission.
- TeraWatt Technology — Electrifying all for the sustainable future
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
Kyogin Lease & Capital is an investment firm that specializes in the leasing, stock and bond investment and public offering consulting.
Show more
Investment focus
- Manufacturing, Task Management, Medical
- Funding Round, Series A, Series B
- Japan
Portfolio highlights
- KOMPEITO — Office de Yasai is an online platform that enables users to order and get vegetables delivered to their offices. The platform’s operations are based in Tokyo, Japan.
- Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
- Towing — Towing is an agricultural company that provides farming, manufacturing, and recycling services.
Sosei CVC is support the creation and growth of life science companies.
Show more
Investment focus
- Biotechnology, Medical, Pharmaceutical
- Funding Round, Series A, Series B
- Japan
Portfolio highlights
- Junten Bio — JUNTEN BIO is a company is to develop new technologies in the field of regenerative medicine.
- Chromocenter — Chromocenter is a next generation biopharmaceuticals Manufacturing company. It uses technologies such as artificial chromosome vectors, mainly for drug discovery such as medical pharmaceuticals
- Noile-Immune Biotech — Neurymune Biotech Co., Ltd. is a national cancer research center specializing in the development of cancer immunotherapies based on CAR-T cell therapy and a venture company from Yamaguchi University. They aim to be a leading company responsible for the next generation in the field of cancer immunotherapy.
Angel Bridge is a angel investor groups in Japan and provide high quality and abundant funds to excellent companies.
Show more
Investment focus
- Information Technology, Software, Consulting
- Series A, Seed, Funding Round
- Japan
Portfolio highlights
- Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
- Goals — Goals specializes in development, sales and operational support for cloud services for food service companies.
- Mechano Cross — Mechano Cross is a mechanical company that offers mechanochemical organic synthesis technology for solution reactions.
Essential Pharma provided on this site is created for the purpose of providing information on our ethical drugs to medical professionals
Show more
Investment focus
- Medical, Biotechnology, Genetics
- Series A, Funding Round
- Japan
Portfolio highlights
- HACARUS — We make AI work, where common Big Data aproaches fail. Get explainable results, even from small data amounts. Available on the cloud or as embedded devices.
- HekaBio — HekaBio connects world-leading healthcare innovations to unmet medical needs in the Asia Pacific, with broad category development expertise in pharma, medical device, in-vitro diagnostics, digital health, and cell & gene therapies.
- Jiksak Bioengineering — Jiksak Bioengineering is a biotechnology company. Jiksak Bioengineering provide an efficient screening service using a three-dimensional cell tissue "Nerve Organoid". We will mainly develop screening technologies specifically for neurodegenerative diseases and search for drugs that are effective for amyotrophic lateral sclerosis (ALS).
Primal Capital, an independent venture capital " incubator bait fund at ", served as the Associate than July 2012 Hiroshi was Sasaki is the venture capital fund that serves as the representative partner. Representative of Sasaki, the seed acceleration program "Incubate Camp" operated by Incubate bait fund is carried out a totalof four times of planning and management than in 2012, They have also engaged in support operations of portfolio companies. - See more at: https://www.crunchbase.com/organization/primal-capital#sthash.m2z1DCbt.dpuf
Show more
Investment focus
- Software, Information Technology, Internet
- Seed, Funding Round, Pre-Seed
- Japan, Spain, Switzerland
Portfolio highlights
- Hivello — Hivello is a Decentralized Physical Infrastructure Network aggregator. Contribute resources, connect with Web3 protocols, and effortlessly generate passive income.
- RemitAid — RemitAid is a fintech company that operates an overseas payment platform for cross-border transactions between companies.
- xCARE — xCARE specializes in the development and commercialization phases of the pharmaceutical and medical device industries.
Spiral Capital is a venture capital fund.
Show more
Investment focus
- Software, Information Technology, Internet
- Funding Round, Series A, Series B
- Japan, United Kingdom
Portfolio highlights
- HITOTSU — HITOTSU is a software development company that provides medical device management systems for all hospitals and clinics.
- Miresso — Miresso is a startup firm that offers nuclear fusion power generation services through natural resources.
- StoryHub — StoryHub is a powerful all-in-one AI editing assistant designed to help users create high-quality content quickly, efficiently, and at a significantly lower cost. Whether you're drafting blog posts, polishing articles, scripting videos, or refining marketing copy, StoryHub streamlines the entire content creation process with intelligent tools
Global Brain Corporation is a venture capital firm that invests in companies from seed or early to pre-IPO startups. Global Brain has invested in 300+ startups from seed/early to pre-IPO startups and achieved 25 IPOs and 61 M&As as a result of providing hands-on support services and resources to its portfolio startups. Global Brain hasmanaged a pure investment fund as well as multiple corporate venture capital funds partnered together with tier 1 public companies of telecom, real estate development, financial service, beverages, agriculture food, logistics, and electronic devices.
Show more
Investment focus
- Information Technology, Software, Artificial Intelligence
- Series A, Series B, Funding Round
- Japan, United States, United Kingdom
Portfolio highlights
- SAKANA Dream — Japanese fish and its cuisine are a treasure of Japan, On the other hand, the variety of fish consumed on a daily basis accounts for less than 1% of all fish living in Japanese waters. Although there are many underutilized fish that surpass the well-known fish, they are even discarded due to unstable catches and lack of name recognition. Aquaculture can provide a stable supply, however, it is not easy to keep fish in a small water cage and only a limited number of fish are delivered to the market. We, SAKANA Dream, select the most delicious fish from over 4,000 species in Japan, and make it possible to farm and produce them using the cutting edge technology. Our goal is to create the "world's most delicious fish" that no one has ever tasted before and deliver it to our customers.
- Cierpa & Company — Cierpa & Company develops environmental, social, and governance management software. They offer services for the cloud, share information between departments, optimise workflows, and analyse and improve scores.
- Counter Culture Company — Counter Culture Company is an online platform that offers K-pop dance classes ranging from beginner to professional levels.
Capital Medica Ventures is a venture capital firm based in Tokyo, Japan with a focus on startups in the healthcare industry.Capital Medica Ventures is a venture capital that operates a venture fund specializing in the healthcare field. It is the only healthcare-specialized VC in Japan that can provide 30 medical institutions as a business trialfield.
Show more
Investment focus
- Medical, Software, Health Care
- Seed, Series A, Funding Round
- Japan
Media Future is a group of communication technology professionals that works on connecting feelings and thoughts.
The Tokyo, Tokyo-based company was established in 2013.
Show more
Investment focus
- Medical, Biotechnology, Genetics
- Series A, Funding Round
- Japan
Portfolio highlights
- HACARUS — We make AI work, where common Big Data aproaches fail. Get explainable results, even from small data amounts. Available on the cloud or as embedded devices.
- HekaBio — HekaBio connects world-leading healthcare innovations to unmet medical needs in the Asia Pacific, with broad category development expertise in pharma, medical device, in-vitro diagnostics, digital health, and cell & gene therapies.
- Jiksak Bioengineering — Jiksak Bioengineering is a biotechnology company. Jiksak Bioengineering provide an efficient screening service using a three-dimensional cell tissue "Nerve Organoid". We will mainly develop screening technologies specifically for neurodegenerative diseases and search for drugs that are effective for amyotrophic lateral sclerosis (ALS).
Cosmo Bio provides the most up-to-date products and technical information available from world-class manufacturers, to laboratories, research institutes, life-science education and testing organizations throughout Japan and around the world. They are proud that their ability to supply a vast array of products and information allows us to serve theneeds of all of their customers. By making full use of their international network, coupled with the highest quality information, they support the life sciences community with a level of commitment and responsibility befitting a company that is trusted by its valued customers.
Show more
Investment focus
- Medical, Biotechnology, Pharmaceutical
- Seed
- Japan
Portfolio highlights
- Fimecs — FIMECS is a protein degradation technology-based drug discovery biotech focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The human body is comprised of at least 18,097 proteins.It has been revealed that 1,500 of them are related to certain diseases, nevertheless only about 300proteins have been regarded as druggable targets by small molecule drug discovery and all the rest have been undruggable.
- Lab Biotech — Lab Biotech manufactures, conducts research, devises plans, and consults with pharmaceutical and food manufacturers.
Kobe University Capital is create new indstry academia cllabration and technology transfer models.
Show more
Investment focus
- Apps, Health Care, Health Diagnostics
- Series A
- Japan
Portfolio highlights
- Pittan — PITTAN is a health tech startup that focuses on the development of high-speed analytical equipment for use in the healthcare industry. The company's primary service is to analyze the internal status of an individual's body to promote beautiful and healthy skin. This is achieved through the application of analytical chemistry.PITTAN's services are designed to provide insights into the body's health, which can be used to inform personal care and wellness decisions.
- TelaAxon — TelaAxon develops artificial intelligence technology for sustainable operations, enhancing human-AI coexistence, safety, and wellness.
- Alpha Fusion — Alpha Fusion Inc. is a clinical-stage startup committed to transforming cancer treatment through the design and development of powerful and precise radiopharmaceuticals.
Glocalink provides seed funding and comprehensive support for emerging science & technology entrepreneurs. Members of Glocalink have extensive experiences of bringing laboratory technologies to the market. On top of seed funding, we will provide comprehensive supports for overcoming all the hurdles that science / technology entrepreneursface.
Show more
Investment focus
- Health Care, Robotics, Task Management
- Funding Round, Seed, Series A
- Japan, Singapore
Portfolio highlights
- MOVeLOT — MOVeLOT is an AI company that provides skeletal platform and robot planning, development, and production services.
- ExtraBold — ExtraBold specializes in the development of 3D printers.
- Kisui Tech — Kisui Tech is an agricultural AI robotics company that help farmers for farming.
TechAccel Ventures is a Seed and Early-Stage Venture Capital firm focused on technology startups in Japan. The firm contributes to the development of the Japanese industry by providing investment and support based on a technical perspective.
Show more
Investment focus
- Manufacturing, Information Technology, Information Services
- Funding Round, Series A, Series B
- Japan, United States
Portfolio highlights
- SIRU+ — SIRU+ is a startup that enables you to convert consumer purchasing data into nutrients and visualize and quantify consumer shopping trends. Through the app developed by the company, consumers can know their nutrition status. The service “SIRU+ (SIRU+)” is an app that lets you know the nutrition of what you bought by simply registering a super pointcard.
- EAGLYS — EAGLYS provides a platform for secure computing and AI.
- KOALA Tech — Koala Tech Inc. is an innovative high-tech startup company, whose goal is to pioneer practical applications of the world's first organic semiconductor laser diode that has been realized in the Center for Organic Photonics and Electronics Research (OPERA) at Kyushu University.
Coral Capital is a seed stage venture capital firm in Japan.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Series A, Series B
- Japan, United States
Portfolio highlights
- Lens — Lens ocuses on supporting corporate activities related to governance, risk management, compliance (GRC), and security.
- CoLab — CoLab is a technology company that provides robotics, artificial intelligence solutions, and business consulting services.
- NutmegLabs — NutmegLabs takes care of tourism and leisure by helping with online booking and digitizing the business. It was founded in 2019 and is based in San Francisco, California, United States.
NEC Capital Solutions Limited provides financial services in Japan.
It's Main Business is Leasing for Information and Communication Equipment, Office Equipment, Industrial Equipment and Installment Sales, Business Loans, Factoring Services, Business Outsourcing and Sales of Used Equipment.
Show more
Investment focus
- Internet, Manufacturing, Information Technology
- Funding Round, Series B, Series A
- Japan, United States, Tanzania
Portfolio highlights
- GITAI — GITAI is a robotics startup for space development. The company aims to replace astronauts with robots that can work for a long time while being remotely controlled from earth while in low earth orbit space stations to decrease the burden on astronauts, shorten the time it takes to perform work in space, and reduce costs.
- Luup — Luup is an Internet Company.
- S-Mat — Smartmat is an eco-friendly IoT purchase system for on-demand, no-hassle grocery with cost-effective shipping.
Yokohama Capital as a venture capital firm conducts investment and rehabilitation support for small and medium-sized companies.
Show more
Investment focus
- Health Care, Artificial Intelligence, Information Technology
- Funding Round, Series A, Seed
- Japan
Portfolio highlights
- GooPass — GooPass is a subscription-based camera equipment rental platform that offers users cameras, interchangeable lenses, and drones. It also allows users to buy or rent photography equipment by reserving it online.
- NABLA Mobility — Solving the complexities involved in the "Operation of Fleets" of Mobility and support its evolution and decarbonization
- Reborna Biosciences — Reborna Biosciences provides research and development in the field of genetic diseases. The company develops therapeutic options for area of unmet medical needs in genetic rare disease. The company's technology enables low-molecular compounds to target ribonucleic acid. The company provides new disease-modifying drugs for patients sufferingfrom rare genetic diseases including spinal muscular atrophy.
Higegin Capital is a venture capital firm.
Show more
Investment focus
- Biotechnology, Medical Device, Medical
- Funding Round, Series A, Series B
- Japan
Portfolio highlights
Investors by industry
Google
Marketplace
Hardware
Energy
Proptech
Health Care
Biotech
Artificial intelligence
Climate
Consumer
Community
Impact
Gaming
FinTech
EdTech
Sustainability
Venture Capital
Big Data
Web3
B2B
Financial Services
Finance
Infrastructure
Education
Photography
Payments
Food and Beverage
Video Games
Organic Food
Retail
Beauty
Publishing
Clean Energy
Real Estate
Manufacturing
Art
Music
Android
Internet
Enterprise Software
eSports
Franchise
Sports
Construction
Digital Media
Email
Medical
Social Network
Wellness
Social Media
Mobile
Legal
Local
Recruiting
Cannabis
Platforms
Fitness
Travel
Mobile Advertising
Biotechnology
Hospitality
Social
Automotive
Crowdfunding
Wine And Spirits
Medical Device
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Theatre
Film
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
United Kingdom
Canada
South Korea
Ireland
United States
New Zealand
India
Germany
Australia
Armenia
South Africa
Spain
Japan
Africa
China
Sri Lanka
Singapore
Qatar
Asia
Indonesia
Vietnam
Oceania
LATAM
Middle East
Europe
Saudi Arabia
Brazil
Bulgaria
Belize
Bahrain
Croatia
Georgia
Belarus
Hungary
France
Ghana
Ethiopia
Gibraltar
Chile
Egypt
Liechtenstein
Liberia
Lebanon
Mauritius
Peru
Finland
Norway
Israel
Malaysia
Costa Rica
Mexico
Nicaragua
Greece
Jersey
Panama
Morocco
Barbados
Mali
Belgium
Lithuania
Estonia
Italy
Philippines
Bermuda
Kuwait
Czech Republic
Malta
Myanmar
Sierra Leone
El Salvador
Uganda
Denmark
Venezuela
Sweden
Slovenia
Poland
Uruguay
Algeria
Ukraine
Tajikistan
Hong Kong
Puerto Rico
Portugal
Tunisia
Taiwan
Tanzania
Ecuador
Turkey
San Marino
Senegal
Togo
Uzbekistan
Serbia
Russian Federation
Zambia
Rwanda
Zimbabwe
Thailand
Dominican Republic
Faroe Islands
Azerbaijan
Iceland
Nigeria
Bahamas
United Arab Emirates
Namibia
Iraq
Jamaica
Honduras
Luxembourg
Isle of Man
Bolivia
Pakistan
Albania
Kenya
Grenada
Jordan
Romania
Bangladesh
Argentina
Kazakhstan
Cayman Islands
Cambodia
Oman
Latvia
Cyprus
Seychelles
Austria
Switzerland
Cameroon
Colombia
Guatemala
Marshall Islands
VC (Venture Capital) Funds in Japan by industry
Crowdfunding
Restaurants
Real Estate
Financial Services
Transportation
Big Data
Cryptocurrency
Finance
Climate
Food and Beverage
Wine And Spirits
Video Games
Medical
Medical Device
Wellness
Internet
Social Media
Digital Media
Manufacturing
Art
Music
Mobile
Android
Blockchain
Legal
Software
Local
Construction
Enterprise Software
Sports
Fitness
Hospitality
Automotive
Travel
InsurTech
FinTech
Recruiting
Biotechnology
Enterprise
Consumer
Health Care
Biotech
Energy
EdTech
Sustainability
Proptech
SaaS
Marketplace
Hardware
Gaming
Retail
Fashion
Beauty
B2B
Life Science
Sporting Goods
Publishing
Photography
Education
Renewable Energy
Mobile Apps
Social
Social Network
Platforms
Clean Energy
Payments
Artificial intelligence
Organic Food
Infrastructure
Web3
Social Impact
Media (entertainment)
Machine Learning
CleanTech
Impact
Community
eSports
Agriculture (agtech)